NEW YORK, April 4 (GenomeWeb News) - Oxford Genome Sciences has closed a second round of venture capital investment, the company said today. The size of the investment was not disclosed.
Oxfordsaid the financing has allowed it to move into a larger custom-built proteomics facility near Oxford, UK. The funding will also be used to accelerate the company's growth, primarily through partnerships.
According to Oxford, the South East Growth Fund, an existing investor, led the round. Oxford Capital Partners participated as a new investor.